While Repligen Corp has underperformed by -1.67%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, RGEN fell by -15.03%, with highs and lows ranging from $182.52 to $102.96, whereas the simple moving average fell by -9.95% in the last 200 days.
On July 22, 2025, Stephens started tracking Repligen Corp (NASDAQ: RGEN) recommending Overweight. A report published by Barclays on June 24, 2025, Initiated its previous ‘Overweight’ rating for RGEN. Wolfe Research also Upgraded RGEN shares as ‘Outperform’, setting a target price of $160 on the company’s shares in a report dated April 29, 2025. Evercore ISI Initiated an In-line rating on March 18, 2025, and assigned a price target of $155. TD Cowen initiated its ‘Buy’ rating for RGEN, as published in its report on February 10, 2025. Canaccord Genuity’s report from December 17, 2024 suggests a price prediction of $165 for RGEN shares, giving the stock a ‘Hold’ rating. Wolfe Research also rated the stock as ‘Peer Perform’.
Analysis of Repligen Corp (RGEN)
Further, the quarter-over-quarter increase in sales is 14.81%, showing a positive trend in the upcoming months.
In order to gain a clear picture of Repligen Corp’s future performance, a variety of well-rounded analysis and research techniques can be applied, with equity being the most critical. The goal here is to ensure that your current return on equity of -0.68% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 7.32, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
An average volume of 822.19K can be a very valuable indicator of volatility for RGEN stock. On a monthly basis, the volatility of the stock is set at 3.86%, whereas on a weekly basis, it is put at 4.24%, with a gain of 7.72% over the past seven days. Furthermore, long-term investors anticipate a median target price of $180.00, showing growth from the present price of $122.3, which can serve as yet another indication of whether RGEN is worth investing in or should be passed over.
How Do You Analyze Repligen Corp Shares?
In addition to the fundamentals, you should also consider how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 5.51%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 98.06% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
